BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 1354540)

  • 1. Effects of peptidase inhibition on angiotensin receptor agonist and antagonist potency in rabbit isolated thoracic aorta.
    Robertson MJ; Cunoosamy MP; Clark KL
    Br J Pharmacol; 1992 May; 106(1):166-72. PubMed ID: 1354540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological characterization of angiotensin-induced depolarizations of rat superior cervical ganglion in vitro.
    Hawcock AB; Barnes JC; Michel AD
    Br J Pharmacol; 1992 Mar; 105(3):686-90. PubMed ID: 1628155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative vasoconstrictor effects of angiotensin II, III, and IV in human isolated saphenous vein.
    Li Q; Feenstra M; Pfaffendorf M; Eijsman L; van Zwieten PA
    J Cardiovasc Pharmacol; 1997 Apr; 29(4):451-6. PubMed ID: 9156353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological profile of GR117289 in vitro: a novel, potent and specific non-peptide angiotensin AT1 receptor antagonist.
    Robertson MJ; Barnes JC; Drew GM; Clark KL; Marshall FH; Michel A; Middlemiss D; Ross BC; Scopes D; Dowle MD
    Br J Pharmacol; 1992 Dec; 107(4):1173-80. PubMed ID: 1467838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different types of antagonism by losartan and irbesartan on the effects of angiotensin II and its degradation products in rabbit arteries.
    Li Q; Pfaffendorf M; van Zwieten PA
    Fundam Clin Pharmacol; 2001 Apr; 15(2):143-50. PubMed ID: 11468024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of aminopeptidase inhibitors on angiotensin-induced pressor responses.
    Sullivan MJ; Harding JW; Wright JW
    Brain Res; 1988 Jul; 456(2):249-53. PubMed ID: 3208081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct positive chronotropic effects of angiotensin II and angiotensin III in pithed rats and in rat isolated atria.
    Li Q; Zhang J; Pfaffendorf M; van Zwieten PA
    Br J Pharmacol; 1996 Aug; 118(7):1653-8. PubMed ID: 8842428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Binding, degradation and pressor activity of angiotensins II and III after aminopeptidase inhibition with amastatin and bestatin.
    Abhold RH; Sullivan MJ; Wright JW; Harding JW
    J Pharmacol Exp Ther; 1987 Sep; 242(3):957-62. PubMed ID: 3656120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amastatin and bestatin-induced dipsogenicity in the Sprague-Dawley rat.
    Quirk WS; Harding JW; Wright JW
    Brain Res Bull; 1987 Jul; 19(1):145-7. PubMed ID: 3651838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intracerebroventricularly infused [D-Arg1]angiotensin III, is superior to [D-Asp1]angiotensin II, as a pressor agent in rats.
    Wright JW; Roberts KA; Cook VI; Murray CE; Sardinia MF; Harding JW
    Brain Res; 1990 Apr; 514(1):5-10. PubMed ID: 2357530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different types of receptor interaction of peptide and nonpeptide angiotensin II antagonists revealed by receptor binding and functional studies.
    Wienen W; Mauz AB; Van Meel JC; Entzeroth M
    Mol Pharmacol; 1992 Jun; 41(6):1081-8. PubMed ID: 1614410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intracerebroventricularly applied peptidase inhibitors increase endogenous angiotensin levels.
    Batt CM; Jensen LL; Hanesworth JM; Harding JW; Wright JW
    Brain Res; 1990 Oct; 529(1-2):126-30. PubMed ID: 2282487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endogenous aminopeptidase N decreases the potency of peptide agonists and antagonists of the kinin B1 receptors in the rabbit aorta.
    Fortin JP; Gera L; Bouthillier J; Stewart JM; Adam A; Marceau F
    J Pharmacol Exp Ther; 2005 Sep; 314(3):1169-76. PubMed ID: 15919764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological classification of alpha 1-adrenoceptors mediating contractions of rabbit isolated ear artery: comparison with rat isolated thoracic aorta.
    Fagura MS; Lydford SJ; Dougall IG
    Br J Pharmacol; 1997 Jan; 120(2):247-58. PubMed ID: 9117117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pressor responses to amastatin, bestatin and Plummer's inhibitors are suppressed by pretreatment with the angiotensin receptor antagonist sarthran.
    Batt CM; Klein EW; Harding JW; Wright JW
    Brain Res Bull; 1988 Nov; 21(5):731-5. PubMed ID: 3219604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of angiotensin II antagonists on the contractile and hydrosmotic effect of AT II and AT III in the toad (Bufo arenarum).
    Peral de Bruno M; Coviello A
    J Comp Physiol B; 1996; 165(7):565-70. PubMed ID: 8617893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of angiotensin receptor blockade in the rabbit aorta: influence of the endothelium.
    le Tran Y; Forster C
    Can J Physiol Pharmacol; 1996 Dec; 74(12):1277-86. PubMed ID: 9047036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of the aminopeptidase inhibitors amastatin and bestatin on angiotensin-evoked neuronal activity in rat brain.
    Harding JW; Felix D
    Brain Res; 1987 Oct; 424(2):299-304. PubMed ID: 3676828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular reactivity of isolated thoracic aorta of the C57BL/6J mouse.
    Russell A; Watts S
    J Pharmacol Exp Ther; 2000 Aug; 294(2):598-604. PubMed ID: 10900237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative effects of angiotensin II and angiotensin III in rabbit adrenal and aortic tissues.
    Pendleton RG; Gessner G; Horner E
    J Pharmacol Exp Ther; 1991 Feb; 256(2):614-20. PubMed ID: 1993998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.